Cargando…
Pilot study of a social network intervention for heroin users in opiate substitution treatment: study protocol for a randomized controlled trial
BACKGROUND: Research indicates that 3% of people receiving opiate substitution treatment (OST) in the UK manage to achieve abstinence from all prescribed and illicit drugs within 3 years of commencing treatment, and there is concern that treatment services have become skilled at engaging people but...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3765136/ https://www.ncbi.nlm.nih.gov/pubmed/23958332 http://dx.doi.org/10.1186/1745-6215-14-264 |
_version_ | 1782283231726403584 |
---|---|
author | Day, Edward Copello, Alex Seddon, Jennifer L Christie, Marilyn Bamber, Deborah Powell, Charlotte George, Sanju Ball, Andrew Frew, Emma Freemantle, Nicholas |
author_facet | Day, Edward Copello, Alex Seddon, Jennifer L Christie, Marilyn Bamber, Deborah Powell, Charlotte George, Sanju Ball, Andrew Frew, Emma Freemantle, Nicholas |
author_sort | Day, Edward |
collection | PubMed |
description | BACKGROUND: Research indicates that 3% of people receiving opiate substitution treatment (OST) in the UK manage to achieve abstinence from all prescribed and illicit drugs within 3 years of commencing treatment, and there is concern that treatment services have become skilled at engaging people but not at helping them to enter a stage of recovery and drug abstinence. The National Treatment Agency for Substance Misuse recommends the involvement of families and wider social networks in supporting drug users’ psychological treatment, and this pilot randomized controlled trial aims to evaluate the impact of a social network-focused intervention for patients receiving OST. METHODS AND DESIGN: In this two-site, early phase, randomized controlled trial, a total of 120 patients receiving OST will be recruited and randomized to receive one of three treatments: 1) Brief Social Behavior and Network Therapy (B-SBNT), 2) Personal Goal Setting (PGS) or 3) treatment as usual. Randomization will take place following baseline assessment. Participants allocated to receive B-SBNT or PGS will continue to receive the same treatment that is routinely provided by drug treatment services, plus four additional sessions of either intervention. Outcomes will be assessed at baseline, 3 and 12 months. The primary outcome will be assessment of illicit heroin use, measured by both urinary analysis and self-report. Secondary outcomes involve assessment of dependence, psychological symptoms, social satisfaction, motivation to change, quality of life and therapeutic engagement. Family members (n = 120) of patients involved in the trial will also be assessed to measure the level of symptoms, coping and the impact of the addiction problem on the family member at baseline, 3 and 12 months. DISCUSSION: This study will provide experimental data regarding the feasibility and efficacy of implementing a social network intervention within routine drug treatment services in the UK National Health Service. The study will explore the impact of the intervention on both patients receiving drug treatment and their family members. TRIAL REGISTRATION: Trial Registration Number: ISRCTN22608399 ISRCTN22608399 registration: 27/04/2012 Date of first randomisation: 14/08/2012 |
format | Online Article Text |
id | pubmed-3765136 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-37651362013-09-07 Pilot study of a social network intervention for heroin users in opiate substitution treatment: study protocol for a randomized controlled trial Day, Edward Copello, Alex Seddon, Jennifer L Christie, Marilyn Bamber, Deborah Powell, Charlotte George, Sanju Ball, Andrew Frew, Emma Freemantle, Nicholas Trials Study Protocol BACKGROUND: Research indicates that 3% of people receiving opiate substitution treatment (OST) in the UK manage to achieve abstinence from all prescribed and illicit drugs within 3 years of commencing treatment, and there is concern that treatment services have become skilled at engaging people but not at helping them to enter a stage of recovery and drug abstinence. The National Treatment Agency for Substance Misuse recommends the involvement of families and wider social networks in supporting drug users’ psychological treatment, and this pilot randomized controlled trial aims to evaluate the impact of a social network-focused intervention for patients receiving OST. METHODS AND DESIGN: In this two-site, early phase, randomized controlled trial, a total of 120 patients receiving OST will be recruited and randomized to receive one of three treatments: 1) Brief Social Behavior and Network Therapy (B-SBNT), 2) Personal Goal Setting (PGS) or 3) treatment as usual. Randomization will take place following baseline assessment. Participants allocated to receive B-SBNT or PGS will continue to receive the same treatment that is routinely provided by drug treatment services, plus four additional sessions of either intervention. Outcomes will be assessed at baseline, 3 and 12 months. The primary outcome will be assessment of illicit heroin use, measured by both urinary analysis and self-report. Secondary outcomes involve assessment of dependence, psychological symptoms, social satisfaction, motivation to change, quality of life and therapeutic engagement. Family members (n = 120) of patients involved in the trial will also be assessed to measure the level of symptoms, coping and the impact of the addiction problem on the family member at baseline, 3 and 12 months. DISCUSSION: This study will provide experimental data regarding the feasibility and efficacy of implementing a social network intervention within routine drug treatment services in the UK National Health Service. The study will explore the impact of the intervention on both patients receiving drug treatment and their family members. TRIAL REGISTRATION: Trial Registration Number: ISRCTN22608399 ISRCTN22608399 registration: 27/04/2012 Date of first randomisation: 14/08/2012 BioMed Central 2013-08-19 /pmc/articles/PMC3765136/ /pubmed/23958332 http://dx.doi.org/10.1186/1745-6215-14-264 Text en Copyright © 2013 Day et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Study Protocol Day, Edward Copello, Alex Seddon, Jennifer L Christie, Marilyn Bamber, Deborah Powell, Charlotte George, Sanju Ball, Andrew Frew, Emma Freemantle, Nicholas Pilot study of a social network intervention for heroin users in opiate substitution treatment: study protocol for a randomized controlled trial |
title | Pilot study of a social network intervention for heroin users in opiate substitution treatment: study protocol for a randomized controlled trial |
title_full | Pilot study of a social network intervention for heroin users in opiate substitution treatment: study protocol for a randomized controlled trial |
title_fullStr | Pilot study of a social network intervention for heroin users in opiate substitution treatment: study protocol for a randomized controlled trial |
title_full_unstemmed | Pilot study of a social network intervention for heroin users in opiate substitution treatment: study protocol for a randomized controlled trial |
title_short | Pilot study of a social network intervention for heroin users in opiate substitution treatment: study protocol for a randomized controlled trial |
title_sort | pilot study of a social network intervention for heroin users in opiate substitution treatment: study protocol for a randomized controlled trial |
topic | Study Protocol |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3765136/ https://www.ncbi.nlm.nih.gov/pubmed/23958332 http://dx.doi.org/10.1186/1745-6215-14-264 |
work_keys_str_mv | AT dayedward pilotstudyofasocialnetworkinterventionforheroinusersinopiatesubstitutiontreatmentstudyprotocolforarandomizedcontrolledtrial AT copelloalex pilotstudyofasocialnetworkinterventionforheroinusersinopiatesubstitutiontreatmentstudyprotocolforarandomizedcontrolledtrial AT seddonjenniferl pilotstudyofasocialnetworkinterventionforheroinusersinopiatesubstitutiontreatmentstudyprotocolforarandomizedcontrolledtrial AT christiemarilyn pilotstudyofasocialnetworkinterventionforheroinusersinopiatesubstitutiontreatmentstudyprotocolforarandomizedcontrolledtrial AT bamberdeborah pilotstudyofasocialnetworkinterventionforheroinusersinopiatesubstitutiontreatmentstudyprotocolforarandomizedcontrolledtrial AT powellcharlotte pilotstudyofasocialnetworkinterventionforheroinusersinopiatesubstitutiontreatmentstudyprotocolforarandomizedcontrolledtrial AT georgesanju pilotstudyofasocialnetworkinterventionforheroinusersinopiatesubstitutiontreatmentstudyprotocolforarandomizedcontrolledtrial AT ballandrew pilotstudyofasocialnetworkinterventionforheroinusersinopiatesubstitutiontreatmentstudyprotocolforarandomizedcontrolledtrial AT frewemma pilotstudyofasocialnetworkinterventionforheroinusersinopiatesubstitutiontreatmentstudyprotocolforarandomizedcontrolledtrial AT freemantlenicholas pilotstudyofasocialnetworkinterventionforheroinusersinopiatesubstitutiontreatmentstudyprotocolforarandomizedcontrolledtrial |